GEG
Great Elm Group, Inc.
There isn't enough reported data to score GEG yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
GEG Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Healthy | |
| Strong |
GEG's cash flow and balance sheet are currently healthy, and its revenue is stable, but its profitability is weak.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
GEG PE Valuation
GEG has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
GEG Forward outlook
There aren't enough analyst estimates for GEG to show an outlook.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
GEG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.07 | -1883% |
| Q2 2026 | -$1.17 | -408% |
| Q1 2026 | -$0.76 | -$0.69 |
| Q4 2025 | -$0.48 | -$0.48 |
| Q3 2025 | $0.06 | +$0.11 |
| Q2 2025 | $0.38 | +$0.43 |
| Q1 2025 | -$0.07 | +$0.08 |
| Q4 2024 | $0.00 | -100% |
GEG has swung to a loss: it lost $1.07 per share over the past year, after a profit the year before.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over GEG on earnings, with more consistent year-over-year improvement.
GEG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3M | -69% |
| Q2 2026 | $10.6M | +88% |
| Q1 2026 | $3.4M | +6.5% |
| Q4 2025 | $3M | -14% |
| Q3 2025 | $10.8M | +170% |
| Q2 2025 | $5.6M | -37% |
| Q1 2025 | $3.2M | +15% |
| Q4 2024 | $3.5M | +24% |
GEG's revenue has slid since its 2022 peak: $3M last quarter, down 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -104% | -70 points |
| Q2 2026 | -20% | +6.6 points |
| Q1 2026 | -116% | -37 points |
| Q4 2025 | -141% | -84 points |
| Q3 2025 | -35% | +16 points |
| Q2 2025 | -26% | -5.9 points |
| Q1 2025 | -80% | -13 points |
| Q4 2024 | -56% | +39 points |
GEG's operating margin was −104% last quarter, down 70 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over GEG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over GEG on profitability, with a higher operating margin.
GEG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10.6M | -378% |
| Q2 2026 | $7.9M | +265% |
| Q1 2026 | $5.8M | +$7.2M |
| Q4 2025 | -$1.9M | +$2.2M |
| Q3 2025 | $3.8M | +$9.6M |
| Q2 2025 | $2.2M | -27% |
| Q1 2025 | -$1.3M | -198% |
| Q4 2024 | -$4M | +$9.7M |
GEG usually generates cash, though not every quarter: the latest was −$11M, but it generated $1M over the past year.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over GEG on cash flow, with more consistent year-over-year improvement.
GEG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -554K shares |
| 1 year | +2.6% | +763K shares |
| 3 years | +2.5% | +738K shares |
| 5 years | +15% | +4M shares |
| Available history | +17% | +4.3M shares |
GEG has 30M diluted shares, up 2.6% from a year ago, despite $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $581,000 |
| Q2 2026 | $596,000 |
| Q1 2026 | $2.8M |
| Q4 2025 | $2.6M |
| Q3 2025 | $756,000 |
| Q2 2025 | $922,000 |
| Q1 2025 | $1.1M |
| Q4 2024 | $3.1M |
GEG spent $7M buying back its own shares over the past year, up 13% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over GEG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
GEG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | -15.6x | Net Cash |
| Q1 2022 | -12.4x | Net Cash |
| Q4 2021 | -6.4x | Net Cash |
| Q3 2021 | -4.3x | Net Cash |
| Q4 2019 | 8.6x | High |
GEG has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
GEG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 22.8 | Neutral |
GEG's weekly RSI is 48 (neutral) and its Stochastic is 23 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
GEG PE vs Healthcare Sector
| Metric | GEG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
GEG has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
GEG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.16 | 0% above |
| 20 week MA | $2.17 | 0.5% below |
| 50 week MA | $2.20 | 1.8% below |
| 100 week MA | $2.17 | 0.5% below |
| 200 week MA | $2.06 | 4.9% above |
GEG has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
GEG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $3.48 | $2.72 | -22% |
| 2021 | $2.72 | $2.07 | -24% |
| 2022 | $2.07 | $1.99 | -3.9% |
| 2023 | $1.99 | $1.94 | -2.5% |
| 2024 | $1.94 | $1.82 | -6.2% |
| 2025 | $1.82 | $2.44 | +34% |
| 2026 YTD | $2.44 | $2.16 | -11% |
GEG has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.